【ChiCTR2100044026】Effects of high-intensity aerobic training with high protein diet in childhood obesity following COVID-19 infection.
ChiCTR2100044026
结束
/
/
/
2021-03-06
/
/
Childhood obesity
Effects of high-intensity aerobic training with high protein diet in childhood obesity following COVID-19 infection.
Clinical (BMI & MRI) and biochemical (Adiponectin, leptin, TNF-α & IL-6) effects of high-intensity aerobic training with high protein diet in childhood obesity following COVID-19 infection.
To find the clinical and biochemical effects of high-intensity aerobic training with a high protein diet in childhood obesity following COVID-19 infection
随机平行对照
上市后药物
A two block simple random sampling method was used to randomize and allocated them into two groups through sealed envelopes. The group A was treated with high-intensity aerobic training with high protein diet (n = 38) and the group B (n = 38) was considered as control group
Not stated
Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia
/
38
/
2020-03-15
2021-01-15
/
Positive diagnosis of COVID-19 male children with 5 – 12 years of age was recruited for the study. Body mass index (BMI) between 85th to 99th percentiles was considered for childhood obesity and included in the study.；
请登录查看Subjects with a history of physical training, taking medications, recent surgeries, fractures and joint problems in lower extremity, cardiac and respiratory problems, neurological issues, major psychiatric problems, any other systemic diseases, contraindications for physical training and family with food restrictions were excluded from the study.；
请登录查看Prince sattam bin abdulaziz University, Al Kharj, Saudi Arabia
/
Prince sattam bin abdulaziz University, Al Kharj, Saudi Arabia的其他临床试验
沙特阿拉伯Prince sattam bin abdulaziz University, Al Kharj, Saudi Arabia的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04